Colistin use in a carbapenem-resistant Enterobacterales outbreak at a South African neonatal unit
Southern African Journal of Infectious Diseases · 30.01.2023 · 38 (1)
DOI: 10.4102/sajid.v38i1.487 ↗Kurz gefasst
Fachartikel in der Zeitschrift Southern African Journal of Infectious Diseases, online erschienen am 30.01.2023. Verfasst von Ilhaam Abrahams und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FIC NIH HHS.
Abstract (Originalsprache)
Background
Colistin is increasingly prescribed for neonates with carbapenem-resistant Enterobacterales (CRE) infections.
Objectives
We described patient demographics, infection episodes, treatment and clinical outcomes, colistin related adverse events and relatedness of isolates in neonates with clinically confirmed or clinically suspected CRE infections.
Method
The authors retrospectively reviewed culture-confirmed and clinically suspected culture-negative CRE infections at a South African neonatal unit during a CRE outbreak.
Results
Fifty-three neonates (median gestational age 29 weeks and birth weight 1185 g) were included. Twenty-three of 53 neonates (43%) had culture-confirmed CRE (17 received colistin; 6 died without receiving colistin) and 30 (57%) received colistin for clinically suspected CRE infection but were ultimately culture-negative. Prior respiratory support and surgical conditions were present in 37/53 (70%) and 19/53 (36%) neonates, respectively. Crude mortality was high (20/53; 38%) with no significant difference between culture-confirmed CRE versus clinically suspected culture-negative CRE groups (10/23 [44%] vs 10/30 [33%]; p = 0.45). Hypomagnesaemia (10/38; 26%) and hypokalaemia (15/38; 40%) were frequent; acute kidney injury was rare (1/44; 2%). Three CRE infection clusters were identified by genotypic analysis of 20 available isolates (18 [90%] blaNDM-1 [New Delhi metallo-beta-lactamase], 2 [10%] blaOXA [oxacillinase]-48).
Conclusion
Neonates receiving colistin therapy were predominantly preterm, with multiple risk factors for infection. Colistin-associated electrolyte derangement was frequent. Over one-third of neonates died. BlaNDM-1 was the most frequent carbapenemase gene identified in the outbreak isolates.Contribution: Colistin was safely used during an Enterobacterales outbreak in predominantly premature and surgical neonates. The mortality was high.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
- Division of Medical Microbiology, Department of Pathology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
- National Health Laboratory Service, Tygerberg Hospital, Cape Town, South Africa.
ORCID-Profile: Ilhaam Abrahams, Angela Dramowski, Kedisaletse Moloto, Lizel Lloyd, Andrew Whitelaw, Adrie Bekker
Förderung
- FIC NIH HHS
Zitieren
APA
Abrahams, I., Dramowski, A., Moloto, K., Lloyd, L., Whitelaw, A., & Bekker, A. (2023). Colistin use in a carbapenem-resistant Enterobacterales outbreak at a South African neonatal unit. Southern African Journal of Infectious Diseases, 38(1). https://doi.org/10.4102/sajid.v38i1.487
Vancouver
Abrahams I, Dramowski A, Moloto K, Lloyd L, Whitelaw A, Bekker A. Colistin use in a carbapenem-resistant Enterobacterales outbreak at a South African neonatal unit. Southern African Journal of Infectious Diseases. 2023;38(1). doi:10.4102/sajid.v38i1.487
BibTeX
@article{Abrahams2023,
author = {Abrahams, Ilhaam and Dramowski, Angela and Moloto, Kedisaletse and Lloyd, Lizel and Whitelaw, Andrew and Bekker, Adrie},
title = {Colistin use in a carbapenem-resistant Enterobacterales outbreak at a South African neonatal unit},
journal = {Southern African Journal of Infectious Diseases},
year = {2023},
volume = {38},
number = {1},
doi = {10.4102/sajid.v38i1.487}
}
EUVIMED